<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Matrix metalloproteinase-9 (MMP-9) has been implicated in the breakdown of the blood-brain barrier during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>As a result, inhibition of MMP-9 may have utility as a therapeutic intervention in <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Towards this end, we have synthesized a series of 1-hydroxy-2-pyridinones that have excellent in vitro potency in inhibiting MMP-9 in addition to MMP-2 </plain></SENT>
<SENT sid="3" pm="."><plain>Representative compounds also demonstrate good efficacy in the mouse transient mid-cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>